COVID-19

Due to the COVID-19 situation, we are unable to take on any new projects.

Please contact us by email with any questions.

Close window
This message will not appear again for another 7 days

Pages

COVID-19 Precision Panc Glasgow Cancer Assays Join The Team Case Studies Information News Clinical Implementation Therapeutic Development Medical Genomics Our Collaborations Facilities Research Team Privacy Policy Divisions Contact Us About Home

Posts

GPOL to provide genomic sequencing for mesothelioma Scottish scientists play a key part of new ‘comprehensive’ map of cancer genomes Groundbreaking new cancer test? GPOL at Festival of Genomics Italy Cancer Network to Pilot the Glasgow Cancer Test Wolfson Wohl Cancer Research Centre 5th Anniversary New Glasgow Cancer Assays by GPOL and Agilent Technologies Professor Biankin recognised in Queen’s Birthday Honours Precision medicine test offers hope to cancer patients Glasgow experts lead UK pancreatic cancer research

Team

Katharine Herbert David Stewart Assya Legrini Meenakshi Ramjee Eugenia Martin Holly Leslie Peter McHardy Amanda Ewing Judith Dixon-Hughes Dr Stephan Dreyer Andrew Biankin Donna Ramsay Sarah Allison Alistair Ritchie Brian McDade Selma Rebus Rosie Upstill-Goddard Dr Nigel Jamieson David Meltzer Dr Philip Beer Dr David Chang Anna Morris Shane Kelly Dr Paul Grimwood John Marshall Dr Susie Cooke

Glasgow Precision Oncology Laboratory

Home | Archives for March 2020

News

The latest news from GPOL

Learn more about our work through our latest media releases and blog posts.

GPOL to provide genomic sequencing for mesothelioma

GPOL will provide genomic sequencing for the University of Glasgow-led PREDICT-Meso (Pre-malignant drivers combined with target-drug validation in mesothelioma), a new £5 million mesothelioma project…